Intravenous infusion of magnesium sulfate is not associated with cardiovascular, liver, kidney, and metabolic toxicity in adults
Journal Title: Journal of Clinical and Translational Research - Year 2018, Vol 4, Issue 1
Abstract
Background: Magnesium (Mg) deficiency contributes to the pathophysiology of numerous diseases. The therapeutic use of Mg has steadily increased over time. The increased in-hospital use of intravenous (IV) magnesium sulfate (MgSO4) warrants more extensive investigation regarding the safety of the therapy. The aim of this study was to determine the safety of IV MgSO4 infusion on cardiovascular, liver, kidney, and metabolic markers in adults. Methods: Twelve volunteers were randomized to one of two cross-over conditions: (a) IV infusion of MgSO4 in 5% dextrose followed by IV infusion of 5% dextrose 1 week later or (b) IV infusion of 5% dextrose followed by IV infusion of MgSO4 in 5% dextrose 1 week later. An electrocardiogram was recorded continuously during the infusions. Blood was drawn pre- and post-infusion for blood count (high-density lipoprotein cholesterol, low-density lipoprotein cholesterol, and triglycerides). Results: Serum Mg increased from pre- to post-infusion in the MgSO4 + 5% dextrose group (p < 0.0001). The QRS interval length increased from pre- to post-infusion in the MgSO4 + 5% dextrose group (p <0.04). Additionally, serum glucose concentration increased in the MgSO4 + 5% dextrose group (p =0.04). These significant findings were modeled with gender and age as covariates. No other significant differences were found. Conclusions: The administration of IV infusion of MgSO4 (4 g/100 mL) in 5% dextrose over a 4-hour treatment period poses no significant deleterious effects on cardiovascular, liver, kidney, or metabolic function. Relevance for patients: IV infusion of MgSO4 may be used for certain treatment indications without significant concern for systemic or organ toxicity.
Authors and Affiliations
Elisa Karhu, Steven E. Atlas1, Jinrun Gao, Syed A. Mehdi, Dominique Musselman, Sharon Goldberg,Judi M. Woolger, Raul Corredor, Muhammad H. Abbas, Leopoldo Arosemena, Simone Caccamo, Ashar Farooqi, Janet Konefal, Laura Lantigua, Vanessa Padilla, Ammar Rasul, Eduard Tiozzo, Oscar L. Higuera, Andrea Fiallo, John E. Lewis
Keywords
Related Articles
- EP ID EP678768
- DOI -
- Views 175
- Downloads 0
Keeping track of all ongoing colorectal cancer trials using a mobile application: Usability and satisfaction results of the Dutch Colorectal Cancer Group Trials application
Background and Aim: Both the number and complexity of medical trials are increasing vastly. To facilitate easy access to concise trial information, a freely available mobile application including all ongoing clinical tri...
Effects of a combination of non-pharmaceutical psychological interventions on dental anxiety
Background: Dental anxiety is a common problem associated with poorer oral health. Managing anxiety is key to improving oral health of patients with dental anxiety. The present pilot study therefore investigated dental a...
Platelet aggregation but not activation and degranulation during the acute post-ischemic reperfusion phase in livers with no underlying disease
Background: Platelets and P-selectin (CD62P) play an unequivocal role in the pathology of hepatic ischemia/reperfusion (I/R) injury. Inhibition or knock-out of P-selectin or immunodepletion of platelets results in amelio...
Laser-assisted vessel welding: state of the art and future outlook
Laser-assisted vascular welding (LAVW) is an experimental technique being developed as an alternative to suture anastomosis. In comparison to mechanical anastomosis, LAVW is less traumatic, non-immunogenic, provides imme...
Biomarkers for glioblastoma multiforme: status quo
Background: Glioblastoma (GBM) is the most frequent and most malignant central nervous system (CNS) tumor. GBM shows poor prognosis with a median overall survival of 14.6 months, despite current surgical and adjuvant the...